Voyageur Pharmaceuticals Ltd. filed its Annual on Mar 30, 2023 for the period ending Nov 30, 2022. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.065 CAD | +44.44% | +30.00% | -13.33% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.33% | 4.58M | |
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- VM Stock
- News Voyageur Pharmaceuticals Ltd.
- Voyageur Pharmaceuticals Ltd. Auditor Raises 'Going Concern' Doubt